Blocking pro-cell-death signal pathways to conserve hearing

Audiology and Neurotology

Volumn 14, Issue 6, 2009, Pages 383-392

  Dinh, Christine T ^a   Van De Water, Thomas R ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Antioxidants; Apoptosis; Cochlea; Corticosteroids; Hearing loss; JNK inhibitors

Indexed keywords

ADRENAL CORTEX HORMONES; ANIMALS; ANTIOXIDANTS; APOPTOSIS; CYTOKINES; HAIR CELLS, AUDITORY; HEARING; HEARING LOSS; HUMANS; INFLAMMATION; ORGAN OF CORTI; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 73349097860     PISSN: 14203030     EISSN: 14219700     Source Type: Journal    
DOI: 10.1159/000241895     Document Type: Review

References (68)

1. Agrawal Y, Platz EA, Niparko JK: Prevalence of hearing loss and differences by demographic characteristics among US adults: Data from the National Health and Nutrition Examination Survey, 1999-2004. Arch Intern Med 2008; 168: 1522-1530.
2. Desai M, Pratt LA, Lentzner H, Robinson KN: Trends in vision and hearing among older Americans. Aging Trends 2001; 2: 1-8.
3. Ichimiya I, Yoshida K, Hirano T, Suzuki M, Mogi G: Significance of spiral ligament fibrocytes with cochlear inflammation. Int J Pediatr Otorhinolaryngol 2000; 56: 45-51. (Pubitemid 30829534)
4. Micheau O, Tschopp J: Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 2003; 114: 181-190.
5. Muppidi JR, Tschopp J, Siegel RM: Life and death decisions: Secondary complexes and lipid rafts in TNF receptor family signal transduction. Immunity 2004; 21: 461-465.
6. Zou J, Pyykkö I, Sutinen P, Toppila E: Vibration induced hearing loss in guinea pig cochlea: Expression of TNF-- and VEGF. Hear Res 2005; 202: 13-20.
7. Fujioka M, Kanzaki S, Okano HJ, Masuda M, Ogawa K, Okano H: Proinflammatory cytokines expression in noise-induced damaged cochlea. J Neurosci 2006; 83: 575-583.
8. So H, Kim HJ, Lee JH, Park C, Kim Y, Kim E, Kim JK, Yun KJ, Lee KM, Lee HY, Moon SK, Lim DJ, Park R: Cisplatin cytotoxicity of auditory cells requires secretions of proinflammatory cytokines via activation of ERK and NF-- B. J Assoc Res Otolaryngol 2007; 8: 338-355.
9. Zine A, Van De Water TR: The MAPK/JNK signalling pathway offers potential therapeutic targets for the prevention of acquired deafness. Curr Drug Targets CNS Neurol Disord 2004; 3: 325-332.
10. Darrat I, Ahmad N, Seidman K, Seidman MD: Auditory research involving antioxidants. Curr Opin Otolaryngol Head Neck Surg 2007; 15: 358-363.
11. Yoshida K, Ichimiya I, Suzuki M, Mogi G: Effect of proinflammatory cytokines on cultured spiral ligament fibrocytes. Hear Res 1999; 137: 155-159.
12. Satoh H, Firestein GS, Billings PB, Harris JP, Keithley EM: Tumor necrosis factor-alpha, an initiator, and etanercept, an inhibitor of cochlear inflammation. Laryngoscope 2002; 112: 1627-1634.
13. Satoh H, Firestein GS, Billings PB, Harris JP, Keithley EM: Proinflammatory cytokine expression in the endolymphatic sac during inner ear inflammation. J Assoc Res Otolaryngol 2003; 4: 139-147.
14. Aminpour S, Tinling SP, Brodie HA: Role of tumor necrosis factor-alpha in sensorineural hearing loss after bacterial meningitis. Otol Neurotol 2005; 26: 602-609.
15. Van Wijk F, Staecker H, Keithley E, Lefebvre PP: Local perfusion of the tumor necrosis factor alpha blocker infliximab to the inner ear improves autoimmune neurosensory hearing loss. Audiol Neurootol 2006; 11: 357-365.
16. Ichimiya I, Yoshida K, Hirano T, Suzuki M, Mogi G: Significance of spiral ligament fibrocytes with cochlear inflammation. Int J Pediatr Otorhinolaryngol 2000; 56: 45-51. (Pubitemid 30829534)
17. Ichimiya I, Yoshida K, Suzuki M, Mogi G: Expression of adhesion molecules by cultured spiral ligament fibrocytes stimulated with proinflammatory cytokines. Ann Otol Rhinol Laryngol 2003; 112: 722-728.
18. Maeda K, Yoshida K, Ichimiya I, Suzuki ML: Dexamethasone inhibits tumor necrosis factor-alpha-induced cytokine secretion from spiral ligament fibrocytes. Hear Res 2005; 202: 154-160.
19. Dinh CT, Haake S, Chen S, Hoang K, Nong E, Eshraghi AA, Balkany TJ, Van De Water TR: Dexamethasone protects organ of Corti explants against tumor necrosis factor-alpha-induced loss of auditory hair cells and alters the expression levels of apoptosis-related genes. Neuroscience 2008; 157: 405-413.
20. Dinh C, Hoang K, Haake S, Chen S, Angeli S, Nong E, Eshraghi AA, Balkany TJ, Van De Water TR: Biopolymer-released dexamethasone prevents tumor necrosis factor alphainduced loss of auditory hair cells in vitro: Implications toward the development of a drug-eluting cochlear implant electrode array. Otol Neurotol 2008; 29: 1012-1019.
21. Takemura K, Komeda M, Yagi M, Himeno C, Izumikawa M, Doi T, Kuriyama H, Miller JM, Yamashita T: Direct inner ear infusion of dexamethasone attenuates noise-induced trauma in guinea pig. Hear Res 2004; 196: 58-68.
22. Tabuchi K, Murashita H, Sakai S, Hoshino T, Uemaetomari I, Hara A: Therapeutic time window of methylprednisolone in acoustic injury. Otol Neurotol 2006; 27: 1176-1179.
23. Tahera Y, Meltser I, Johansson P, Bian Z, Stierna P, Hansson AC, Canlon B: NF-kappaB mediated glucocorticoid response in the inner ear after acoustic trauma. J Neurosci Res 2006; 1;83: 1066-1076.
24. Hashimoto K, Seki M, Miyasaka H, Watanabe K: Effect of steroids on increased permeability of blood vessels of the stria vascularis after auditory ossicle vibration by a drill in otologic surgery. Ann Otol Rhinol Laryngol 2006; 115: 769-774.
25. Himeno C, Komeda M, Izumikawa M, Takemura K, Yagi M, Weiping Y, Doi T, Kuriyama H, Miller JM, Yamashita T: Intra-cochlear administration of dexamethasone attenuates aminoglycoside ototoxicity in the guinea pig. Hear Res 2002; 167: 61-70.
26. Park SK, Choi D, Russell P, John EO, Jung TT: Protective effect of corticosteroid against the cytotoxicity of aminoglycoside otic drops on isolated cochlear outer hair cells. Laryngoscope 2004; 114: 768-771. (Pubitemid 38548795)
27. Tabuchi K, Oikawa K, Murashita H, Hoshino T, Tsuji S, Hara A: Protective effects of glucocorticoids on ischemia-reperfusion injury of outer hair cells. Laryngoscope 2006; 116: 627-629.
28. Kim HH, Addison J, Suh E, Trune DR, Richter CP: Otoprotective effects of dexamethasone in the management of pneumococcal meningitis: An animal study. Laryngoscope 2007; 117: 1209-1215.
29. Eshraghi AA, Adil E, He J, Graves R, Balkany TJ, Van De Water TR: Local dexamethasone therapy conserves hearing in an animal model of electrode insertion trauma-induced hearing loss. Otol Neurotol 2007; 28: 842-849.
30. Vivero RJ, Joseph DE, Angeli S, He J, Chen S, Eshraghi AA, Balkany TJ, Van de Water TR: Dexamethasone base conserves hearing from electrode trauma-induced hearing loss. Laryngoscope 2008; 118: 2028-2035.
31. Conlin AE, Parnes LS: Treatment of sudden sensorineural hearing loss. I. A systematic review. Arch Otolaryngol Head Neck Surg 2007; 133: 573-581.
32. Conlin AE, Parnes LS: Treatment of sudden sensorineural hearing loss. II. A meta-analysis. Arch Otolaryngol Head Neck Surg 2007; 133: 582-586.
33. Haynes DS, O'Malley M, Cohen S, Watford K, Labadie RF: Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy. Laryngoscope 2007; 117: 3-15.
34. Hamid M, Trune D: Issues, indications, and controversies regarding intratympanic steroid perfusion. Curr Opin Otolaryngol Head Neck Surg 2008; 16: 434-440.
35. Wei BP, Mubiru S, O'Leary S: Steroids for idiopathic sudden sensorineural hearing loss. Cochrane Database Syst Rev 2006; 1: CD003998.
36. Swan EE, Mescher MJ, Sewell WF, Tao SL, Borenstein JT: Inner ear drug delivery for auditory applications. Adv Drug Deliv Rev 2008; 60: 1583-1599.
37. Haake S, Dinh CT, Chen S, Eshraghi AA, Van De Water TR: Dexamethasone protects auditory hair cells against TNF--initiated apoptosis via activation of PI3K/Akt and NF- B signaling. Hear Res 2009, E-pub ahead of print.
38. Krishna M, Narang H: The complexity of mitogen-activated protein kinases (MAPKs) made simple. Cell Mol Life Sci 2008; 65: 3525-3544.
39. Wang J, Van De Water TR, Bonny C, de Ribaupierre F, Puel JL, Zine A: A peptide inhibitor of c-Jun N-terminal kinase protects against both aminoglycoside and acoustic trauma-induced auditory hair cell death and hearing loss. J Neurosci 2003; 23: 8596-8607.
40. Lei K, Nimnual A, Zong WX, Kennedy NJ, Flavell RA, Thompson CB, Bar-Sagi D, Davis RJ: The Bax subfamily of Bcl2-related proteins is essential for apoptotic signal transduction by c-Jun NH(2)-terminal kinase. Mol Cell Biol 2002; 22: 4929-4942.
41. Bonny C, Oberson A, Negri S, Sauser C, Schorderet DF: Cell-permeable peptide inhibitors of JNK: Novel blockers of beta-cell death. Diabetes 2001; 50: 77-82.
42. Barkdull GC, Hondarrague Y, Meyer T, Harris JP, Keithley EM: AM-111 reduces hearing loss in a guinea pig model of acute labyrinthitis. Laryngoscope 2007; 117: 2174-2182.
43. Coleman JK, Littlesunday C, Jackson R, Meyer T: AM-111 protects against permanent hearing loss from impulse noise trauma. Hear Res 2007; 226: 70-78.
44. Eshraghi AA, He J, Mou CH, Polak M, Zine A, Bonny C, Balkany TJ, Van De Water TR: D-JNKI-1 treatment prevents the progression of hearing loss in a model of cochlear implantation trauma. Otol Neurotol 2006; 27: 504-511.
45. Eshraghi AA, Wang J, Adil E, He J, Zine A, Bublik M, Bonny C, Puel JL, Balkany TJ, Van De Water TR: Blocking c-Jun-N-terminal kinase signaling can prevent hearing loss induced by both electrode insertion trauma and neomycin ototoxicity. Hear Res 2007; 226: 168-177.
46. Bennett BL, Sasaki DT, Murray BW, O'Leary EC, Sakata ST, Xu W, Leisten JC, Motiwala A, Pierce S, Satoh Y, Bhagwat SS, Manning AM, Anderson DW: SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci USA 2001; 98: 13681-13686.
47. Marderstein EL, Bucher B, Guo Z, Feng X, Reid K, Geller DA: Protection of rat hepatocytes from apoptosis by inhibition of c-Jun N-terminal kinase. Surgery 2003; 134: 280-284.
48. Minutoli L, Altavilla D, Marini H, Passaniti M, Bitto A, Seminara P, Venuti FS, Famulari C, Macrì A, Versaci A, Squadrito F: Protective effects of SP600125 a new inhibitor of c-jun N-terminal kinase (JNK) and extracellular-regulated kinase (ERK1/2) in an experimental model of cerulein-induced pancreatitis. Life Sci 2004; 75: 2853-2866.
49. Sharma N, Suzuki H, He Q, Sharma RP: Tumor necrosis factor alpha-mediated activation of c-Jun NH(2)-terminal kinase as a mechanism for fumonisin B(1) induced apoptosis in murine primary hepatocytes. J Biochem Mol Toxicol 2005; 19: 359-367.
50. Assi K, Pillai R, Gómez-Muñoz A, Owen D, Salh B: The specific JNK inhibitor SP600125 targets tumour necrosis factor-alpha production and epithelial cell apoptosis in acute murine colitis. Immunology 2006; 118: 112-121.
51. Kato T, Noma H, Kitagawa M, Takahashi T, Oshitani N, Kitagawa S: Distinct role of c-Jun N-terminal kinase isoforms in human neutrophil apoptosis regulated by tumor necrosis factor-alpha and granulocyte-macrophage colony-stimulating factor. J Interferon Cytokine Res 2008; 28: 235-243.
52. Nam SI: Interleukin-1beta up-regulates inducible nitric oxide by way of phosphoinositide 3-kinase-dependent in a cochlear cell model. Laryngoscope 2006; 116: 2166-2170.
53. Jeong HJ, Hong SH, Park RK, Shin T, An NH, Kim HM: Hypoxia-induced IL-6 production is associated with activation of MAP kinase, HIF-1, and NF-kappaB on HEI-OC1 cells. Hear Res 2005; 207: 59-67.
54. Henderson D, Bielefeld EC, Harris KC, Hu BH: The role of oxidative stress in noise-induced hearing loss. Ear Hear 2006; 27: 1-19.
55. Ohinata Y, Miller JM, Schacht J: Protection from noise-induced lipid peroxidation and hair cell loss in the cochlea. Brain Res 2003; 966: 265-273.
56. Neuwelt EA, Gilmer-Knight K, Lacy C, Nicholson HS, Kraemer DF, Doolittle ND, Hornig GW, Muldoon LL: Toxicity profile of delayed high dose sodium thiosulfate in children treated with carboplatin in conjunction with blood-brain-barrier disruption. Pediatr Blood Cancer 2006; 47: 174-182.
57. Blakley BW, Cohen JI, Doolittle ND, Muldoon LL, Campbell KC, Dickey DT, Neuwelt EA: Strategies for prevention of toxicity caused by platinum-based chemotherapy: Review and summary of the annual meeting of the Blood-Brain Barrier Disruption Program, Gleneden Beach, Oregon, March 10, 2001. Laryngoscope 2002; 112: 1997-2001.
58. Doolittle ND, Muldoon LL, Brummett RE, Tyson RM, Lacy C, Bubalo JS, Kraemer DF, Heinrich MC, Henry JA, Neuwelt EA: Delayed sodium thiosulfate as an otoprotectant against carboplatin-induced hearing loss in patients with malignant brain tumors. Clin Cancer Res 2001; 7: 493-500. (Pubitemid 32707970)
59. Dickey DT, Wu YJ, Muldoon LL, Neuwelt EA: Protection against cisplatin-induced toxicities by N-acetylcysteine and sodium thiosulfate as assessed at the molecular, cellular, and in vivo levels. J Pharmacol Exp Ther 2005; 314: 1052-1058.
60. Wimmer C, Mees K, Stumpf P, Welsch U, Reichel O, Suckfüll M: Round window application of D-methionine, sodium thiosulfate, brain-derived neurotrophic factor, and fibroblast growth factor-2 in cisplatin-induced ototoxicity. Otol Neurotol 2004; 25: 33-40.
61. Samson J, Wiktorek-Smagur A, Politanski P, Rajkowska E, Pawlaczyk-Luszczynska M, Dudarewicz A, Sha SH, Schacht J, Sliwinska-Kowalska M: Noise-induced time-dependent changes in oxidative stress in the mouse cochlea and attenuation by D-methionine. Neuroscience 2008; 152: 146-150.
62. Lockwood DS, Ding DL, Wang J, Salvi RJ: D - Methionine attenuates inner hair cell loss in carboplatin-treated chinchillas. Audiol Neurootol 2000; 5: 263-266.
63. Ekborn A, Laurell G, Johnström P, Wallin I, Eksborg S, Ehrsson H: D-Methionine and cisplatin ototoxicity in the guinea pig: D-methionine influences cisplatin pharmacokinetics. Hear Res 2002; 165: 53-61.
64. Kopke RD, Jackson RL, Coleman JK, Liu J, Bielefeld EC, Balough BJ: NAC for noise: From the bench top to the clinic. Hear Res 2007; 226: 114-125.
65. Kramer S, Dreisbach L, Lockwood J, Baldwin K, Kopke R, Scranton S, O'Leary M: Efficacy of the antioxidant N-acetylcysteine (NAC) in protecting ears exposed to loud music. J Am Acad Audiol 2006; 17: 265-278.
66. Kopke RD, Weisskopf PA, Boone JL, Jackson RL, Wester DC, Hoffer ME, Lambert DC, Charon CC, Ding DL, McBride D: Reduction of noise-induced hearing loss using L-NAC and salicylate in the chinchilla. Hear Res 2000; 149: 138-146.
67. Duan M, Qiu J, Laurell G, Olofsson A, Counter SA, Borg E: Dose and time-dependent protection of the antioxidant N-L-acetylcysteine against impulse noise trauma. Hear Res 2004; 192: 1-9. (Pubitemid 38639826)
68. Kopke R, Bielefeld E, Liu J, Zheng J, Jackson R, Henderson D, Coleman JK: Prevention of impulse noise-induced hearing loss with antioxidants. Acta Otolaryngol 2005; 125: 235-243. (Pubitemid 40477189)